Get started
The Joint Corp.The Joint Corp.The Joint Corp.

The Joint Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

JYNT chart


Full chart

JYNT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪166.16 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.97USD
Net income (FY)
‪−9.75 M‬USD
Revenue (FY)
‪117.70 M‬USD
Shares float
‪14.77 M‬
Beta (1Y)
0.79

Employees


Employees (FY)
794
Change (1Y)
+13 +1.66%
Revenue / Employee (1Y)
‪148.23 K‬USD
Net income / Employee (1Y)
‪−12.28 K‬USD

About The Joint Corp.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Sanjiv Razdan
Website
thejoint.com
Headquarters
Scottsdale
Founded
2010
FIGI
BBG0074VSJJ9
The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

JYNT news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of JYNT is 11.10 USD — it has increased by 1.44% in the past 24 hours. Watch The Joint Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange The Joint Corp. stocks are traded under the ticker JYNT.
JYNT stock has fallen by −0.79% compared to the previous week, the month change is a 0.72% rise, over the last year The Joint Corp. has showed a 43.78% increase.
We've gathered analysts' opinions on The Joint Corp. future price: according to them, JYNT price has a max estimate of 20.00 USD and a min estimate of 10.50 USD. Watch JYNT chart and read a more detailed The Joint Corp. stock forecast: see what analysts think of The Joint Corp. and suggest that you do with its stocks.
JYNT reached its all-time high on Sep 7, 2021 with the price of 111.06 USD, and its all-time low was 1.85 USD and was reached on Jul 1, 2016. View more price dynamics on JYNT chart.
See other stocks reaching their highest and lowest prices.
JYNT stock is 2.26% volatile and has beta coefficient of 0.79. Track The Joint Corp. stock price on the chart and check out the list of the most volatile stocks — is The Joint Corp. there?
Today The Joint Corp. has the market capitalization of ‪166.16 M‬, it has decreased by −0.18% over the last week.
Yes, you can track The Joint Corp. financials in yearly and quarterly reports right on TradingView.
The Joint Corp. is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
JYNT earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.02 USD resulting in a ‪−1.25 K‬% surprise. The estimated earnings for the next quarter are 0.01 USD per share. See more details about The Joint Corp. earnings.
The Joint Corp. revenue for the last quarter amounts to ‪30.26 M‬ USD, despite the estimated figure of ‪29.40 M‬ USD. In the next quarter, revenue is expected to reach ‪28.38 M‬ USD.
JYNT net income for the last quarter is ‪−3.60 M‬ USD, while the quarter before that showed ‪946.98 K‬ USD of net income which accounts for −479.78% change. Track more The Joint Corp. financial stats to get the full picture.
No, JYNT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 794.00 employees. See our rating of the largest employees — is The Joint Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. The Joint Corp. EBITDA is ‪8.23 M‬ USD, and current EBITDA margin is 8.51%. See more stats in The Joint Corp. financial statements.
Like other stocks, JYNT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade The Joint Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So The Joint Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating The Joint Corp. stock shows the sell signal. See more of The Joint Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.